Pro Medicus (PME.AX) Saham Harga

Pro Medicus Harga

ASX·DITUTUP
165,69
​
Pasar ditutup

Pendapatan tumbuh 17,3% per tahun selama 19 tahun terakhir menjadi 261,69 Juta. AUD. Laba per saham tumbuh 20,8% per tahun selama 19 tahun terakhir. margin bersih Pro Medicus saat ini 101,4%, naik dari 47,6% beberapa tahun lalu. Pro Medicus saat ini menawarkan imbal hasil dividen sekitar 0,53%. Rasio pembayaran sekitar 73% dari laba. Dividen tumbuh 21,6% per tahun selama 19 tahun terakhir. Target harga median analis adalah 244,80 AUD, di atas harga saat ini sebesar 47,7%. Dari 17 analis, 11 merekomendasikan beli — konsensus keseluruhan Beli.

Harga saham Pro Medicus

Akses data ini lewat Eulerpool API

Model bisnis dan analisis saham Pro Medicus

Pro Medicus Ltd. adalah perusahaan Australia yang mengkhususkan diri dalam pengembangan dan distribusi solusi perangkat lunak pencitraan medis. Perusahaan ini didirikan pada tahun 1983 dan berkantor pusat di Melbourne.

Pertanyaan yang sering diajukan tentang saham Pro Medicus

The business model of Pro Medicus Ltd revolves around providing advanced healthcare imaging software solutions. The company specializes in developing and delivering a comprehensive range of radiology solutions that enhance workflow efficiency and improve patient care. Pro Medicus offers cutting-edge products like Visage AI, Visage 7, and Visage RIS, which allow healthcare professionals to efficiently manage and analyze medical images. By combining innovative technology with a customer-centric approach, Pro Medicus helps healthcare providers worldwide optimize their imaging operations and deliver accurate diagnoses. With its focus on developing state-of-the-art software solutions, Pro Medicus positions itself as a leader in the medical imaging industry.

Pro Medicus Ltd is primarily active in the healthcare industry.

The main competitors of Pro Medicus Ltd in the market include other medical imaging companies such as Carestream Health, Change Healthcare, and Sectra AB. These companies also specialize in providing medical imaging solutions and technology to healthcare providers and are prominent players in the industry. Pro Medicus Ltd competes with them in terms of product offerings, innovation, customer base, and market share.

Pro Medicus Ltd is a renowned healthcare imaging and information technology provider. Established in 1983, the company has a rich history of pioneering innovative solutions in the medical imaging industry. With a strong focus on radiology, Pro Medicus has developed advanced imaging software that improves efficiency and enhances patient care. The company's success is attributed to its commitment to research and development, resulting in cutting-edge technologies and multiple industry awards. Pro Medicus operates globally, serving prominent healthcare institutions and professionals. With its profound expertise and dedication to advancing medical imaging technology, Pro Medicus Ltd continues to lead the industry in providing innovative solutions for the healthcare sector.

Some significant milestones achieved by Pro Medicus Ltd include the successful expansion into major global markets, such as the United States and Europe, further solidifying its position as a leading provider of healthcare imaging solutions. The company has also experienced continuous revenue growth, achieving record-breaking financial results year after year. Pro Medicus Ltd has consistently developed and released innovative software solutions, enhancing efficiency and productivity for healthcare professionals. Additionally, the company has formed strategic partnerships with top-tier healthcare organizations, further establishing its reputation as a trusted industry leader. These accomplishments have propelled Pro Medicus Ltd's growth and success in the competitive healthcare technology sector.

Pro Medicus Ltd primarily operates in Australia and the United States.

Pro Medicus Ltd is a leading healthcare IT solutions provider with a strong commitment to excellence and innovation. The company's core values revolve around delivering exceptional products and services that empower healthcare professionals to enhance patient care and outcomes. Pro Medicus emphasizes a customer-centric approach and strives to provide customized solutions tailored to meet the unique needs of its clients. With a clear focus on technological advancements and high-quality imaging software, Pro Medicus constantly pushes the boundaries in the healthcare industry. By fostering a culture of collaboration and continuous improvement, Pro Medicus Ltd is dedicated to transforming the way medical images are managed and shared worldwide.

Analis saat ini menetapkan target harga rata-rata 226,59 AUD untuk saham Pro Medicus (median: 244,80 AUD), yaitu +36,8 % terhadap harga terbaru. Konsensus didasarkan pada 17 peringkat analis.

17 analis saat ini menilai saham Pro Medicus: 13 merekomendasikan beli, 4 tahan, dan 0 jual.

Dengan kurs saat ini, saham Pro Medicus diperdagangkan pada 103,28 EUR (165,69 AUD).

Saham Pro Medicus (PME.AX) tercatat di 3 bursa, termasuk: ASX (PME.AX), Frankfurt (PMC.F).

Pro Medicus Ltd is a global company specializing in providing advanced IT solutions for the healthcare industry. They offer innovative information and image management solutions that are used by leading healthcare organizations worldwide. Their main divisions include Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Telemedicine. Their PACS solutions allow hospitals and healthcare organizations to store, manage, and share digital images from medical diagnostic devices such as CT, MRI, and X-ray machines. These solutions are scalable and provide high-quality image quality for radiologists and other specialists to make informed diagnoses. Their RIS is an integrated solution designed specifically for radiology departments and practices, providing complete patient and order management, as well as integrated workflow tools to improve the efficiency and accuracy of diagnosing and evaluating medical imaging data. Their telemedicine solutions enable radiology professionals to edit and share medical images remotely over the internet, particularly beneficial in facilities with limited resources or for quick access to medical images in emergency diagnoses. In addition, Pro Medicus Ltd also offers specialized solutions for clinical decision support, automated medical image analysis, and patient management. Their clinical decision support provides assistance to medical professionals in diagnosis and treatment monitoring, while the automated analysis of medical image data allows for the quick processing of large amounts of data, producing results that can be utilized by professionals for diagnostic purposes. Their patient management solutions provide comprehensive capture and management of health data that can be used by doctors and other professionals to develop better treatment options for their patients. Pro Medicus Ltd is a global company with a strong focus on research and development. They have partnerships with leading healthcare organizations worldwide and possess a strong portfolio of intellectual property. Their business model is based on the sale of products and services specifically designed for the needs of the healthcare industry. The company emphasizes innovation, customer satisfaction, and delivering high-quality solutions that are scalable and flexible for various users. Overall, Pro Medicus Ltd is an innovative market leader in the field of medical IT solutions. They are globally recognized for their products and services and are expected to continue playing a significant role in the healthcare industry.

Pendapatan dari Pro Medicus adalah 261,69 Juta. AUD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.

Laba dari Pro Medicus adalah 265,34 Juta. AUD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.

Rasio harga-terhadap-pendapatan (PER) Pro Medicus saat ini adalah 65,34. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Pro Medicus.

Rasio harga-terhadap-penjualan (PSR) Pro Medicus saat ini adalah 66,25. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Pro Medicus.

Skor Kualitas AlleAktien untuk Pro Medicus adalah 8/10.

ISIN dari Pro Medicus adalah AU000000PME8. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.

WKN dari Pro Medicus adalah 591723. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.

Ticker dari Pro Medicus adalah PME.AX. Simbol ticker digunakan untuk memperdagangkan saham Pro Medicus di bursa saham.

Nilai WajarTerminal
157,41 AUD
Penilaian Berlebihan/KurangTerminal
Dinilai secara wajar
Sektor
Industri
Teknologi Kesehatan
Jumlah Saham
Karyawan
Pendapatan per Karyawan
3,31 Juta. AUD
Pertumbuhan Pendapatan Ø5 Tahun
Pertumbuhan EBIT Ø5 Tahun
Pertumbuhan Laba Bersih Ø5 Tahun
Situs Web promed.com.au
Negara
Australia
Mata Uang
AUD
Penawaran Umum Perdana
10 Okt 2000
ISIN
AU000000PME8
CUSIP
Q77301101
SEDOL
6292782
Kapitalisasi Pasar
Kisaran 52 Minggu
Rasio PEG
9,66
P/E 2027
91,22
P/E 2028
72,36
P/E 2029
58,81
P/E 2030
42,84
P/E 2031
65,75
P/S
51,22
EV/EBIT
88,42
Rasio P/B
38,46
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
58,85 %
Dividen
Hasil dividen
0,53 %
Hasil Dividen Estimasi
0,45 %
Rasio Pembayaran
72,54 %
Pertumbuhan dividen Ø5T
23,03 %
Pembayaran dividen per tahun
2
Dividen dibayarkan sejak
14 tahun
Dividen tidak dipotong sejak
10 tahun
Dividen meningkat sejak
10 tahun
Pajak penahan dividen
30,00 %
Terakhir diperbarui 13 Okt 2026, 22.16

Pro Medicus Ticker

ASX · PME.AXFRANKFURT · PMC.FOTC · PMCUF

Pro Medicus FIGI

PME:AU · BBG000C41MZ9PME:AT · BBG000C41NB3PMCUF:US · BBG000H06487PMCUF:UV · BBG000H07L06PME:AH · BBG002F3J5Y3PMC:GR · BBG00GCTJN24PMC:GF · BBG00GCTJN33PMEEUR:EO · BBG00GD4N8Z0PMEEUR:XH · BBG00GD4N924PMEEUR:XF · BBG00GD4N942PMEEUR:XE · BBG00GD4N960PMEEUR:XJ · BBG00GD4N979

Semua metrik fundamental dan analisis mendalam Pro Medicus

Analisis saham kami untuk saham Pro Medicus mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Pro Medicus. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.